So, triplet therapy is not advised? It wasn't covered. ADT + ARSI + Docetaxel
Actually, triplet therapy is a recommended treatment option for certain patients with advanced prostate cancer, and it's well-supported by current evidence.
What Triplet Therapy Is
Triplet therapy combines three medications:
- ADT (androgen deprivation therapy/hormone therapy like Lupron)
- ARSI (androgen receptor signaling inhibitor - drugs like abiraterone, enzalutamide, or darolutamide)
- Docetaxel (chemotherapy)
Current Guidelines and Evidence
According to NCCN Guidelines for Patients, triplet therapy is specifically listed as a treatment option for advanced-stage prostate cancer. The guidelines include combinations like:
- ADT + abiraterone (Zytiga) + docetaxel
- ADT + enzalutamide (Xtandi) + docetaxel
- ADT + darolutamide (Nubeqa) + docetaxel
The ARASENS trial, as discussed in Cancer Commons expert webinars, demonstrated that darolutamide combined with ADT and docetaxel "delayed progression and improved survival" in patients with hormone-sensitive metastatic prostate cancer.
When It's Recommended
Triplet therapy is typically considered for patients with:
- High-volume metastatic disease (multiple bone or organ metastases)
- High-risk features
- Newly diagnosed hormone-sensitive metastatic prostate cancer
Important Considerations
The decision depends on several factors:
- Your overall health and ability to tolerate chemotherapy
- Disease burden and aggressiveness
- Your treatment goals and preferences
- Potential side effects
This is definitely a conversation to have with your oncologist about whether triplet therapy is appropriate for your specific situation, as it can be more intensive than doublet therapy (ADT + ARSI alone) but may offer better outcomes for certain patients.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
- If hormone therapy (ADT) is recommended: How long will I need it? What are the common short-term and long-term side...
- I've finished radiation therapy while continuing on ADT and Abiraterone. How do I know how I'm doing? My...
- There could be a 4th option where the cancer has changed/does not produce PSA
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Prostate Cancer — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated October 31, 2025. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Prostate Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Prostate Cancer patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about Prostate Cancer
- My Prostate Cancer is stable but not shrinking — is treatment still working
- What is Bipolar Androgen Therapy
- Undetectable. is it possible to know if this is due to ongoing ADT vs. cancer absence? How to think about this
- What to consider before ADT surgery or treatment? What questions shoudl I ask
- What physical therapy do I need after Prostate Cancer surgery
- How does epigenetic therapy work for Prostate Cancer
- What is mRNA vaccine therapy for Prostate Cancer
- Is proton therapy an option for Prostate Cancer